16 June 2020 – ECHA’s Member State Committee (MSC) did not agree to identify resorcinol (EC 203-585-2; CAS 108-46-3) as a substance of very high concern (SVHC) due to its endocrine-disrupting properties. Where the MSC is unable to reach a consensus, However, the committee acknowledged that there is scientific evidence that resorcinol is an endocrine disruptor as defined by the World Health Organization (WHO). The European Commission’s REACH Committee will take the final decision.

Reference: https://echa.europa.eu/-/resorcinol-not-identified-as-a-substance-of-very-high-concern


If this regulation is applicable to you and you are interested in knowing more about this topic and available solutions, then schedule a free consult with our experts.